3,118 research outputs found
The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease
BACKGROUNDL: PREDICT-PD is a United Kingdom population-based study aiming to stratify individuals for future Parkinson's disease (PD) using a risk algorithm. METHODS: A randomly selected, representative sample of participants in PREDICT-PD were examined using several motor assessments, including the motor section of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS)-III, at baseline (2012) and after an average of 6 years of follow-up. We checked for new PD diagnoses in participants seen at baseline and examined the association between risk scores and incident sub-threshold parkinsonism, motor decline (increasing ≥5 points in MDS-UPDRS-III) and single motor domains in the MDS-UPDRS-III. We replicated analyses in two independent datasets (Bruneck and Parkinson's Progression Markers Initiative [PPMI]). RESULTS: After 6 years of follow-up, the PREDICT-PD higher-risk group (n = 33) had a greater motor decline compared with the lower-risk group (n = 95) (30% vs. 12.5%, P = 0.031). Two participants (both considered higher risk at baseline) were given a diagnosis of PD during follow-up, with motor signs emerging between 2 and 5 years before diagnosis. A meta-analysis of data from PREDICT-PD, Bruneck, and PPMI showed an association between PD risk estimates and incident sub-threshold parkinsonism (odds ratio [OR], 2.01 [95% confidence interval (CI), 1.55–2.61]), as well as new onset bradykinesia (OR, 1.69 [95% CI, 1.33–2.16]) and action tremor (OR, 1.61 [95% CI, 1.30–1.98]). CONCLUSIONS: Risk estimates using the PREDICT-PD algorithm were associated with the occurrence of sub-threshold parkinsonism, including bradykinesia and action tremor. The algorithm could also identify individuals whose motor examination experience a decline over time
PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
To present methods and baseline results for an online screening tool to identify increased risk for Parkinson's disease (PD) in the UK population
Bone health in Parkinson's disease: a systematic review and meta-analysis
AJN: Travel support from the
National Institute of Health Research for presentations at MDS Congresses and
Association of British Neurologists Meetings; grants from Parkinson’s UK Innovation
Grant (K-1006), Parkinson’s UK Career Development Award (F-1201), National
Institute of Health Research Academic Clinical Fellowship, Élan/Prothena
Pharmaceuticals and GE Healthcare. KMD: beneficiary of a Reta Lila Weston
Scholarship and received a Parkinson’s UK Innovation Grant (K-1010
Management dilemma; a woman with cystic fibrosis and severe lung disease presenting with colonic carcinoma: a case report
Introduction
There are increasing reports of bowel cancer in cystic fibrosis, suggesting a possible causal link. Individuals with cystic fibrosis who have advanced lung disease present a high operative risk, limiting curative treatment options in early bowel malignancy.
Case presentation
We describe a 41-year-old Caucasian woman with cystic fibrosis and severe lung disease who had been considered for lung transplantation, who presented with rectal bleeding and was found to have a Stage I adenocarcinoma of the sigmoid colon. After considerable discussion as to the operative risks, she underwent a laparoscopic resection and remains relatively well 1 year postoperatively with no recurrence.
Conclusion
We discuss the complexity of the management decisions for cystic fibrosis patients with severe lung disease and early stage colonic malignancy, particularly in the context of potential need for lung transplantation. The case demonstrates that cystic fibrosis patients with very severe lung function impairment may undergo laparoscopic abdominal surgical interventions without compromising postoperative airway clearance
Bone health in Parkinson's disease: A systematic review and meta-analysis
Objective: Parkinson's disease (PD) and osteoporosis are chronic diseases associated with increasing age. Single studies have reported associations between them and the major consequence, namely, increased risk of fractures. The aim of this systematic review and meta-analysis was to evaluate the relationship of PD with osteoporosis, bone mineral density (BMD) and fracture risk. Methods: A literature search was undertaken on 4 September 2012 using multiple indexing databases and relevant search terms. Articles were screened for suitability and data extracted where studies met inclusion criteria and were of sufficient quality. Data were combined using standard meta-analysis methods. Results: 23 studies were used in the final analysis. PD patients were at higher risk of osteoporosis (OR 2.61; 95% CI 1.69 to 4.03) compared with healthy controls. Male patients had a lower risk for osteoporosis and osteopenia than female patients (OR 0.45; 95% CI 0.29 to 0.68). PD patients had lower hip, lumbar spine and femoral neck BMD levels compared with healthy controls; mean difference, -0.08, 95% CI -0.13 to -0.02 for femoral neck; -0.09, 95% CI -0.15 to -0.03 for lumbar spine; and -0.05, 95% CI -0.07 to -0.03 for total hip. PD patients were also at increased risk of fractures (OR 2.28; 95% CI 1.83 to 2.83). Conclusions: This systematic review and meta-analysis demonstrate that PD patients are at higher risk for both osteoporosis and osteopenia compared with healthy controls, and that female patients are at greater risk than male patients. Patients with PD also have lower BMD and are at increased risk of fractures. © 2014 by the BMJ Publishing Group Ltd
Constipation preceding Parkinson's disease: a systematic review and meta-analysis
AJN is funded by Parkinson’s UK (grant reference F-1201). AJL has
received honoraria from Novartis, Teva, Meda, Boehringer Ingelheim, GSK, Ipsen,
Lundbeck, Allergan and Orion. AS has received grant money from GE Healthcare
and honoraria from UCB. AJN has received grants from Élan/Prothena
Pharmaceuticals and from GE Healthcare
The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes
Resuscitation-promoting factor (RPF) proteins reactivate stationary-phase cultures of (G+C)-rich Gram-positive bacteria including the causative agent of tuberculosis, Mycobacterium tuberculosis. We report the solution structure of the RPF domain from M. tuberculosis Rv1009 (RpfB) solved by heteronuclear multidimensional NMR. Structural homology with various glycoside hydrolases suggested that RpfB cleaved oligosaccharides. Biochemical studies indicate that a conserved active site glutamate is important for resuscitation activity. These data, as well as the presence of a clear binding pocket for a large molecule, indicate that oligosaccharide cleavage is probably the signal for revival from dormancy
in the Two Higgs Doublet Model up to Next-to-Next-to-Leading Order in QCD
We compute three-loop matching corrections to the Wilson coefficients
and in the Two Higgs Doublet Model by applying expansions for small,
intermediate and large charged Higgs boson masses. The results are used to
evaluate the branching ratio of to next-to-next-to
leading order accuracy, and to determine an updated lower limit on the charged
Higgs boson mass. We find \mhplus \ge 380 GeV at 95% confidence level when
the recently completed BABAR data analysis is taken into account. Our results
for the charged Higgs contribution to the branching ratio exhibit considerably
weaker sensitivity to the matching scale , as compared to previous
calculations.Comment: 20 pages, 15 figures; v2: minor modifications, matches published
version in JHE
- …